DB-3Q

N/A

Report date: 2025/06/04 14:33:18

Base Information

Drug NameDB-3Q

Drug Alias NameDB-3QDB-3Q bmMSC-EV

ClassificationCell and gene therapy > Cell therapy > Donor > AllogeneicBiologics > Extracellular VesiclesCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy +[4]

Mechanisms of ActionCell replacements

TargetsNot applicable

Therapy Area/IndicationsPerianal fistulaCrohn Disease

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesDirect Biologics Llc

China Registration ClassN/A

Develop Information

Active CompaniesDirect Biologics Llc

Inactive CompaniesN/A

Active IndicationsPerianal fistulaCrohn Disease

Inactive IndicationsN/A

Other Information

ATC CodeN/A